About Welex Laboratories Private Limited
Data last updated:
Welex Laboratories Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 23 June 1979 and has been in existence for over 47 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1979PTC021411. Its GSTIN is 27AAACW0756A1ZP (Maharashtra).
The company has an authorised share capital of ₹6 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors Roopam Yeshwant Bhatt (Managing Director) and Priya Bhatt Roopam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1002 A Wing Marathon Innova Ganpatrao Kadam Marg Opp Pennensula Corporate Park, Mumbai, Maharashtra.
As per the financials filed for FY 2022, the company reported a revenue of ₹15.12 Cr. For the same year it recorded a net profit of ₹31.9 Lakh (net margin 2.1%) and EBITDA of ₹2.48 Cr (EBITDA margin 16.4%). Revenue has declined at a compounded annual rate (CAGR) of 8% over three years and 1% over five years.
The company has about 37 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Welex Care. As per MCA filings, the company has open charges of ₹2.3 Cr and satisfied charges of ₹1.11 Cr on record. Court records list 4 cases involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website welexcare.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressA – 1002 A Wing Marathon Innova Ganpatrao Kadam Marg Opp Pennensula Corporate Park Lower Pare, L, Mumbai, Maharashtra, India – 400013
- IndustryHealthcare, Ayurvedic Products & Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Welex Laboratories Private Limited
Welex Laboratories operates one associated brand: Welex Care. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Ayurvedic supplements for chronic health issues in India. | welexcare.com |
Financials of Welex Laboratories Private Limited FY 2025 filings available
Welex Laboratories Private Limited reported revenue of ₹15.12 Cr for FY 2022.
Compounded Annual Growth Rate (CAGR) of Welex Laboratories Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years. EBITDA fell 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Welex Laboratories Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹15.12 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.48 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹31.9 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Welex Laboratories Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Welex Laboratories are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Welex Laboratories Private Limited
Welex Laboratories has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Priya Bhatt Roopam Also directs: Ayuwelex Private Limited | Director | 06 Jan 2007 | 19 Years 9 Months | Current |
| Roopam Yeshwant Bhatt Also directs: Ayuwelex Private Limited | Managing Director | 10 Sep 1997 | 29 Years 1 Months | Current |
Auditor Details of Welex Laboratories Private Limited
Welex Laboratories Private Limited is audited by DALAL DOCTOR & ASSOCIATES for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| DALAL DOCTOR & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Welex Laboratories Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Welex Laboratories Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Aug 1993 | Dena Bank | ₹31 Lakh | Open |
| 26 Jul 1993 | Dena Bank | ₹1.99 Cr | Open |
| 05 Jul 2017 | Others | ₹50 Lakh | Satisfied |
| 06 Aug 2008 | The Saraswat Co-Op Bank Ltd | ₹45 Lakh | Satisfied |
| 17 Oct 1990 | Bank of Baroda | ₹3.75 Lakh | Satisfied |
Total charge records: 7 View all charges
Legal Cases of Welex Laboratories Private Limited
Welex Laboratories Private Limited has 4 court cases on record: 1 filed against it, 3 where it is another party. All cases are disposed. Status as checked between 29 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 0 | 0 |
| High courts | 1 | 1 | 0 |
Cases on record (2 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Tax appeal | Filed against the company by Commissioner of Income Tax -5 | Disposed |
| District court, Ernakulam, Kerala | Criminal case | Company is another party | Disposed |
Full case history
All 4 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Welex Laboratories Private Limited
Welex Laboratories Private Limited has 10 MSME Form 1 returns on record between 2019 and 2024, listing 56 overdue payments to 27 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 27)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 10 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Welex Laboratories Private Limited
Welex Laboratories Private Limited has a workforce of 37 employees as of Apr 09, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Welex Laboratories Private Limited
Welex Laboratories Private Limited has 2 board changes on record since 1997: 2 appointments. The latest: Priya Bhatt Roopam was appointed as Director on 06 Jan 2007.
7 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Welex Laboratories Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Welex Laboratories Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Welex Laboratories Private Limited
Welex Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACW0756A1ZP | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Welex Laboratories Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Welex Laboratories Private Limited
Welex Laboratories is an active private limited company based in Mumbai, Maharashtra, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 23 June 1979 (47+ years old) and is registered under CIN U24230MH1979PTC021411.
Welex Laboratories reported revenue of ₹15.12 Cr for FY 2022.
Welex Laboratories has 2 current directors:
- Roopam Yeshwant Bhatt - Managing Director
- Priya Bhatt Roopam - Director
Welex Laboratories reported a net profit of ₹31.9 Lakh (net margin 2.1%) and EBITDA of ₹2.48 Cr (EBITDA margin 16.4%) for FY 2022, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Welex Laboratories is -8% over three years and -1% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Welex Laboratories is 27AAACW0756A1ZP, registered in Maharashtra.
The CIN (Corporate Identification Number) of Welex Laboratories is U24230MH1979PTC021411. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Welex Laboratories has 4 court cases on record: 1 filed against it. Most are in the district courts.
Welex Laboratories was incorporated on 23 June 1979, making it 47+ years old. It is registered with the Registrar of Companies, Mumbai.
Priya Bhatt Roopam was appointed as Director on 06 Jan 2007. Roopam Yeshwant Bhatt was appointed as Managing Director on 10 Sep 1997.
Welex Laboratories has 10 MSME Form 1 returns on record between 2019 and 2024, listing 56 overdue payments to 27 micro and small suppliers. The latest return was filed on 26 Apr 2024.